News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Boehringer Ingelheim Release: New Real-World Data Show Pradaxa (Dabigatran Etexilate Mesylate) Treatment Resulted In Less Use Of All-Cause Healthcare Resources Than Warfarin Treatment 10/21/2016
Takeda (TKPYY)'s Vedolizumab Demonstrated Robust Clinical Effectiveness And Safety In Inflammatory Bowel Disease In More Than 50 Real-World Studies 10/17/2016
Amgen (AMGN) Release: New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin 10/10/2016
Ampio Pharmaceuticals, Inc. (AMPE) Announces Accepted Publication Of The Clinical Trial Results Of Its Oral Drug, Optina, Treatment Of Diabetic Macular Edema 10/4/2016
PTC Therapeutics (PTCT) Release: New Research Validates Translarna's (Ataluren) Mechanism Of Action To Promote Readthrough Of Nonsense Mutations And Produce Full-Length Functional Protein 10/4/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
Novartis AG (NVS) Late-Breaking Data Show Cosentyx Continues To Deliver High Skin Clearance For Majority Of Psoriasis Patients At Four Years 10/3/2016
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Additional Interim Data Supporting Long-Term Use Of Vedolizumab In Patients With Ulcerative Colitis And Crohn's Disease Published In Journal Of Crohn's And Colitis 9/29/2016
Lubricin Release: Data Demonstrates Significant Improvement In Multiple Signs And Symptoms Of Dry Eye Disease Compared To Sodium Hyaluronate 9/20/2016
Important New Analysis Shows That Novartis Pharmaceutical Corporation (NVS)' Entresto Is Associated With Higher Relative Health-Related Quality Of Life Scores Among HFrEF Patients 9/19/2016
Roche (RHHBY) Says New MS Drug Works Better Than Merck & Co. (MRK)'s Rebif 9/19/2016
DelMar Pharma Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium 9/13/2016
vBloc Institute Demonstrates Positive Clinical Success In Patients Struggling With Weight Loss As Compared To Pivotal FDA Trial With EnteroMedics (ETRM) VBloc Therapy In Combination With VBloc Achieve Program 9/13/2016
Egalet Announces OXAYDO Demonstrates Bioequivalence At 15 Mg Dose 9/12/2016
Kaleo Presents Studies At PAINWeek 2016 Comparing Naloxone Intramuscular Injection And Naloxone Intranasal Administration 9/8/2016
Raptor (RPTP) Presents Results From Meta-Analysis Demonstrating Efficacy Of QUINSAIR Comparable To Other Approved, Inhaled Antibiotics In Cystic Fibrosis Patients 9/7/2016
Boehringer Ingelheim Relelase: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of Ofev (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of OFEV (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: Tiotropium RESPIMAT Improved Lung Function With Safety Comparable To Placebo In Children With Asthma 9/6/2016
Vectura (VEC.L) Release: New Findings Confirm Ultibro Breezhaler Consistently More Effective Than Seretide In Reducing COPD Flare-Ups Across Different Patient Groups 9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials 9/1/2016
Seqirus Presents Analysis Reinforcing The Safety And Immunogenicity Profiles Of Its MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine In Adults 65 Years And Older 8/29/2016
Amgen (AMGN) Announces Positive Top-Line Results From Phase 3 Study Of Prolia (Denosumab) In Patients Receiving Glucocorticoid Therapy 8/29/2016
Amgen (AMGN) Release: New Repatha (evolocumab) Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At European Society of Cardiology Congress 2016 8/29/2016
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors 8/26/2016
Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin 8/25/2016
Sunovion Pharmaceuticals Inc. Announces Publication Of Data Evaluating Dose Escalation Of Latuda (Lurasidone HCL) In The Treatment Of Schizophrenia 8/8/2016
Novo Nordisk A/S (NVO)'s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure 8/4/2016
Imprimis (immy) Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops 7/22/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin 7/21/2016
Pfizer (PFE) Receives WHO Prequalification For Multi-Dose Vial Presentation Of Prevenar 13 7/19/2016
Mallinckrodt (MNK) Warned Over Missing Study About Child Opioids Use 7/8/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance 6/29/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Of INPULSIS Trials Demonstrates Efficacy Of OFEV (Nintedanib) Across A Range Of IPF Patients Using Broader Diagnostic Criteria 6/27/2016
Roche (RHHBY) CEO 'Sleeping Much Better' Following Positive News About Three New Drugs 6/23/2016
FDA Bestows Incyte (INCY)'s Ruxolitinib with Breakthrough Tag for Graft-Versus-Host Disease 6/23/2016
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients 6/21/2016
Pernix (PTX) Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study 6/16/2016
Merck & Co. (MRK) Release: Systematic Review Of 58 Publications Of Real-World Use Of GARDASIL Presented At EUROGIN Congress 6/16/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Significantly Reduced The Risk Of Progressive Kidney Disease In Adults With Type 2 Diabetes With Established Cardiovascular Disease 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: New Study Results Show Trajenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment 6/13/2016
AstraZeneca PLC (AZN) Presents New Data From Multiple Studies On The Effect Of BYDUREON On Glucose Fluctuations In Patients With Type 2 Diabetes 6/13/2016
New Data Presented At The Annual European Congress Of Rheumatology (EULAR 2016) Demonstrate Safety And Efficacy Of Biogen (BIIB)’s Anti-TNF Biosimilars Portfolio 6/9/2016
AstraZeneca PLC (AZN) To Highlight Scientific Advancements Across Its Diabetes Portfolio At The American Diabetes Association 76th Scientific Sessions 6/8/2016
ASCO2016: Caris Life Sciences Introduces Research Showing Time-To-Next Treatment As Effective Surrogate Outcome Measure In Retrospective Study Of 4729 Cancer Patients Undergoing Panomic Profiling 6/7/2016
ASCO2016: CTI BioPharma Long-Term Follow Up Data For Pacritinib Presented At 2016 ASCO Annual Meeting 6/7/2016
ASCO2016: Novartis Pharmaceuticals Corporation (NVS) Combination Therapy Tafinlar + Mekinist Demonstrates Overall Survival Benefit At Three-Year Follow-Up In Patients With Advanced Melanoma 6/7/2016
Array BioPharma (ARRY) Release: Encorafenib-Based Regimens Provide Improved PFS And OS In Difficult-To-Treat BRAF-Mutant Colorectal Cancer Compared To Historical Benchmarks 6/6/2016
ASCO2016: Celgene (CELG) Release: Data Presented At ASCO 2016 Builds Upon Foundation Of Abraxane Plus Gemcitabine As A First-Line Treatment In Patients With Metastatic Pancreatic Cancer 6/6/2016
Novartis Pharmaceuticals Corporation (NVS) Data Show Gilenya Had Significantly Greater Patient Retention Compared To iDMTs In Relapsing-Remitting MS 6/3/2016
Endo International (ENDP) Release: New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA (Buprenorphine) Buccal Film For Chronic Pain 6/3/2016
Study Published In Science Translational Medicine Reports Favorable Safety And Extended Survival For Brain Cancer Patients Treated With Tocagen Inc.'s Cancer-Selective Viral Gene Therapy 6/2/2016
Galderma Laboratories Announces Positive Results From The “Commplete” Regimen Study Including Epiduo Gel In The Management Of Acne In Adolescent Student Athletes 5/24/2016
After Initial Miss, GlaxoSmithKline (GSK)'s Pioneering Lung Study Shows Positive Results 5/24/2016
Relypsa (RLYP) Release: Data From New Analyses Of Studies With Veltassa Presented At 53rd European Renal Association Congress 5/23/2016
Sunovion Pharmaceuticals Inc.Announces Publication Of Data Evaluating The Long-Term Safety And Tolerability Of Latuda (Lurasidone Hcl) In The Treatment Of Bipolar Depression 5/23/2016
STELVIO Trial Shows Sustained Benefits For Emphysema Patients One Year After Treatment With Pulmonx, Inc.'s Zephyr Endobronchial Valves 5/19/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rare Cause Of Nephrotic Syndrome 5/18/2016
BioPharmX Presents At American Congress Of Obstetricians And Gynecologists (ACOG) Suggesting Molecular Iodine May Be Effective, Non-Hormonal Treatment For FBC 5/16/2016
Sunovion Pharmaceuticals Inc. Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 American Thoracic Society Conference 5/16/2016
Egalet Human Abuse Potential Data At American Pain Society Annual Meeting Demonstrates Significantly Lower Intranasal Abuse Potential Of ARYMO ER Compared To MS Contin 5/12/2016
Alimera Sciences (ALIM)' ILUVIEN Data Presented At 2016 Association for Research in Vision & Ophthalmology 5/6/2016
Starpharma Release: VivaGel Active Against Zika Virus 5/5/2016
Biogen (BIIB) R&D Spending Dropped 19% from Last Quarter 4/22/2016
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) To Be Studied For The Treatment Of People With Chronic Heart Failure 4/19/2016
Bristol-Myers Squibb (BMY) Release: First Presentation Of Overall Survival Data For Opdivo (Nivolumab) Shows Significant Survival Benefit At One-Year Versus Investigator’s Choice In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck 4/19/2016
Immune Pharma Release: New Biomarker Data To Be Presented At AACR Helps Predict Overall Survival In Patients With Acute Myeloid Leukemia (AML) Treated With Ceplene And Low-Dose IL-2 Immunotherapy, Including Those Over 60 Years Of Age 4/19/2016
Janssen Release: New Data From U.S. Post-Approval Study Assess Ischemic Stroke And Intracranial Hemorrhage Rates In People With Non-Valvular Atrial Fibrillation Comparing Both Rivaroxaban With Warfarin And Apixaban With Warfarin 4/18/2016
New Data Suggesting Positive Effects Of Sanofi Genzyme (SNY)’s Lemtrada (Alemtuzumab) On Brain Volume Loss And Retinal Nerve Fibers To Be Presented At American Academy of Neurology 4/18/2016
Janssen Release: Real-World Study Further Confirms Safety Profile Of XARELTO In Nearly 45,000 People With Non-Valvular Atrial Fibrillation (NVAF), Including Those With Concomitant Diabetes 4/4/2016
Novo Nordisk A/S (NVO) Release: Victoza (liraglutide [rDNA origin] injection) Provided Superior Hba1c Reductions In Adults With Type 2 Diabetes Compared To Continued Sitagliptin Treatment 4/4/2016
Health Canada Approves BioPharmX Study Of Violet Iodine 4/4/2016
Cardiome Pharma Corp. (COM.TO) Announces Publication Of Independent Study Comparing BRINAVESS To Ibutilide In Patients With Recent-Onset Atrial Fibrillation 3/31/2016
Specialised Therapeutics Asia Release: Novel Multiple Myeloma Drug Aplidin Shows Positive Results In Pivotal Phase 3 Study 3/31/2016
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In Updated American College of Cardiology And AHA Guideline In Acute Coronary Syndrome 3/31/2016
Janssen Research & Development Release: First Phase 3 Trial Of Daratumumab In Combination With Standard Therapy In Relapsed/Refractory Multiple Myeloma Meets Primary Endpoint In Planned Interim Analysis 3/30/2016
Boehringer Ingelheim Launches RE-COVERY DVT/PE: Global Observational Study On Management Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) With Pradaxa (Dabigatran Etexilate) 3/23/2016
AstraZeneca PLC (AZN)'s Brilinta Fails to Hit Main Goal of Stroke Study 3/23/2016
BioPharmX Initiates Post-Market Phase IV Study For Fibrocystic Breast Condition (FBC) And Cyclic Mastalgia 3/22/2016
SoCal's Aerie (AERI) Reports Positive Safety Data for Rhopressa 3/18/2016
Gilead (GILD) Shuts Down Six Zydelig Trials Following European Medicines Agency Review 3/17/2016
Viralytics Ltd (VLA.AX) Release: Positive CAVATAK Clinical Data Presented At 2016 European Association Of Urology Congress 3/15/2016
Janssen Pharmaceuticals, Inc. Release: First Real-World Evidence Comparing An SGLT2 Inhibitor With DPP-4 Inhibitors Shows Adults With Type 2 Diabetes Achieve Greater Blood Glucose Control With INVOKANA (canagliflozin) 3/14/2016
Boehringer Ingelheim Release: New Analyses: Adding SPIRIVA RESPIMAT Effective For Uncontrolled Asthma - Regardless Of Allergy Subtype 3/8/2016
New Novartis AG (NVS) Data Show Cosentyx Demonstrated Sustained Superiority In Skin Clearance (PASI 90) Versus Stelara At Week 52 3/7/2016
Celgene (CELG) Release: Oral OTEZLA (Apremilast) Long-Term Safety Data Presented At American Academy of Dermatology Congress 3/7/2016
AstraZeneca PLC (AZN), Novo Nordisk A/S (NVO) Investors Pin Hopes on Data from Two Closely-Watched Trials 3/2/2016
AEterna Zentaris (AEZS) Reports On Zoptrex Development Progress In China 3/1/2016
Arizona Pharmaceuticals Release: New Analysis Re-Affirms IR-Niacin As Evidence-Based Therapy For Dyslipidemia 3/1/2016
Female Libido Drug that Valeant (VRX) Bought for $1 Billion Gets Mixed Reviews 3/1/2016
Boehringer Ingelheim Release: New Analysis Confirms OFEV® (Nintedanib) Slows Disease Progression In IPF And Reduces Risk Of Acute Exacerbations 2/25/2016
ChromaDex, Inc. Announces Commencement Of An Obesity-Related Clinical Study Of NIAGEN In Collaboration With The University of Copenhagen And Aarhus University 2/22/2016
Amgen (AMGN)'s Aranesp Meets Primary Goal in Late Stage Trial 2/16/2016
Cumberland Pharmaceuticals (CPIX) Release: Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics 2/10/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Newly Published Head-to-Head Data Show STIOLTO RESPIMAT Improved Lung Function Across Range Of Measures 2/9/2016
EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase III Clinical Study For BOW015 (Infliximab Biosimilar) 2/9/2016
Valeant (VRX) Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo 2/3/2016
Journal of Clinical Oncology Publishes Results From The STRIVE Trial Of enzalutamide Compared To bicalutamide In Castration-Resistant Prostate Cancer 1/27/2016
First U.S. Patient Treated Following FDA Approval Of Cook Medical’s Zenith Alpha Thoracic Endovascular Graft 1/26/2016
Omeros Corporation (OMER) Release: Disclosure Of Omidria Post-Launch Study Findings To Occur At Hawaiian Eye And Retina Conference 1/18/2016
Hi-Tech Pharmaceuticals Announces OTC Nationwide Launch Of New Diet Pill -- Ionamin -- Backed By Clinical Study 1/12/2016
Regeneron (REGN) Investors Get Jitters From False Praluent Data 1/8/2016
ImaginAb, Inc.'s PSMA Imaging Agent Detects More Lesions Compared To Standard Imaging Methods For Detection Of Prostate Cancer In Phase I/Ila Study 1/6/2016
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials 1/4/2016
Primary Endpoint Met in Baxalta (BXLT) and Momenta (MNTA)'s Biosimilar Study of Humira 12/22/2015
FDA Grants Fast Track Designation For MediciNova, Inc.'s MN-166 (Ibudilast) For The Treatment Of Amyotrophic Lateral Sclerosis 12/16/2015
Collegium (COLL) Announces Publication Of Nasal Human Abuse Potential Study In American Academy Of Pain Medicine 12/16/2015
Zydelig Study May Finally Transform Gilead (GILD) into a Cancer Powerhouse 12/11/2015
Defective Device Forces Regulators to Take a Hard Look at Bayer (BAY)'s Xarelto Trial 12/9/2015
Merck & Co. (MRK) Release: Findings Across A Range Of Hematological Cancers Add To The Growing Breadth Of KEYTRUDA (Pembrolizumab) Data 12/8/2015
Janssen Pharmaceutical Release: Real-World Data Confirms Safety And Efficacy Profile Of XARELTO, With Shorter Hospital Stays, For The Treatment Of Deep Vein Thrombosis 12/8/2015
ContraVir Reports Key CMX157 Data At HEP DART 2015 Demonstrating Enhanced In Vitro Safety Profile Compared To Viread 12/8/2015
Merck & Co. (MRK) Release: Findings Across A Range Of Hematological Cancers Add To The Growing Breadth Of KEYTRUDA (Pembrolizumab) Data 12/8/2015
SteadyMed (STDY) Demonstrates Potential For Reduced Infusion Site Sensitivity Associated With Trevyent Compared To Remodulin 12/7/2015
AbbVie (ABBV) Release: IMBRUVICA (Ibrutinib) Phase 3 RAY Data Show Significant Reductions In Disease Progression Versus Temsirolimus In Relapsed/Refractory Mantle Cell Lymphoma Patients 12/7/2015
Researchers Find Additional Benefits of Novartis AG (NVS)'s Heart Failure Drug Entresto 12/3/2015
H. Lundbeck A/S (LUN.CO) Release: Largest Prospective Study Evaluating The Effect Of Vigabatrin On Vision 11/25/2015
BioMarin (BMRN) Stocks Drop After FDA Panel is Critical of DMD Treatment Drisapersen 11/23/2015
VBL Therapeutics (VBLX) Announces Significant Improvement Of 12 Month Overall Survival With VB-111 Compared To Pooled Data From Four Avastin Studies At The Annual Meeting Of The Society For Neuro-Oncology 11/19/2015
Astellas (ALPMY) Announces Results From The First Head To Head Study Comparing QUTENZATM (Capsaicin 8% Patch) With Current Standard Of Care In Patients With Peripheral Neuropathic Pain 11/19/2015
Merck & Co. (MRK) Provides Update On REVEAL Outcomes Study 11/13/2015
Pernix Therapeutics Holdings, Inc. Announces Positive Interim Results From A Phase IV Study To Assess And Compare The Effects Of Silenor 6 Mg And Zolpidem 10 Mg On Balance, Cognitive Performance, And Arousability 11/13/2015
AstraZeneca PLC (AZN) Release: PEGASUS-TIMI 54 Sub-Analysis Outlines Long-Term Tolerability Data For BRILINTA 11/10/2015
Boehringer Ingelheim Release: New Jardiance (Empagliflozin) Data Show Improved CV Outcomes Regardless Of Heart Failure Status At Baseline 11/9/2015
ArmaGen Technologies, Inc. Receives Rare Pediatric Disease Designation From FDA For AGT-181 For The Potential Treatment Of Hurler Syndrome (Mucopolysaccharidosis Type I) 11/5/2015
Pfizer (PFE) Release: New Data Continue To Characterize The Safety And Efficacy Of XELJANZ (Tofacitinib Citrate) In The Treatment Of Rheumatoid Arthritis 11/2/2015
FDA Bestows Merck & Co. (MRK)'s Keytruda with Breakthrough Status to Treat Advanced Colorectal Cancer 11/2/2015
Boehringer Ingelheim Release" CHEST: New Sub-Analyses Show Improvement In COPD Patient Outcomes With Spiolto Respimat 10/28/2015
Momenta (MNTA) Announces Publication Of Two Glatopa (Glatiramer Acetate Injection) Manuscripts 10/26/2015
Mundipharma AG: New Study Provides Insights Into Potential Treatment Of Severe Pain In Parkinson’s Disease With Prolonged-Release Oxycodone/Naloxone 10/20/2015
Novartis AG (NVS) Cancer Drug May Help Parkinson's Patients 10/19/2015
Sunovion Pharmaceuticals Inc. To Present Health Outcomes Data Supporting Brovana® (Arformoterol Tartrate) Inhalation Solution In Patients With COPD At The 2015 American College of Chest Physicians Annual Meeting 10/19/2015
EMD Serono Announces Publication Of PRISMS-15 Yr Follow-Up Study In Patients Using Rebif (interferon beta-1a), Focused On Factors Influencing Outcomes In RRMS 10/13/2015
Abbott (ABT)'s Absorb Passes First Large Test 10/13/2015
Indian Drugmakers Like Cipla (CIPLA) and BDR Pharma Work on Hepatitis C Cocktails Impossible in the U.S. 10/12/2015
Amgen (AMGN) Release: New Data Show Greater Bone Mineral Density Gains With Prolia (Denosumab) Compared With Zoledronic Acid 10/12/2015
Gedeon Richter (RIG2.F) Release: Full Results Of PEARL IV Study Presented At The European Society Of Gynaecological Endoscopy (ESGE) Congress Confirms The Efficacy Of Ulipristal Acetate 5 Mg For The Long Term Management Of Uterine Fibroids 10/9/2015
Sanofi Genzyme (SNY) Touts Long-Term Data for Multiple Sclerosis Drug Lemtrada 10/8/2015
Marathon Pharmaceuticals, LLC Receives Rare Pediatric Disease Designation From FDA For Deflazacort As A Potential Treatment Of Duchenne Muscular Dystrophy 10/7/2015
AstraZeneca PLC (AZN) Release: SYMBICORT Real-World Study Results Published In The International Journal Of COPD 9/30/2015
Boehringer Ingelheim Release: New Data Demonstrate Sustained Long-Term Efficacy Of OFEV* On Slowing Disease Progression And Safety In Patients With IPF 9/29/2015
Patients With Aggressive Form Of Melanoma Lived For More Than Two Years On Average When Taking Novartis Pharmaceutical Corporation (NVS) Therapies Tafinlar + Mekinist 9/28/2015
Boehringer Ingelheim Release: New Head-to-Head STIOLTO RESPIMAT Data Presented At ERS Annual Congress 9/28/2015
Alimera Sciences (ALIM) Announces ILUVIEN Study Results Presented At 15th Euretina Congress 9/24/2015
Hemispherx (HEB) Reports Article By Senior Authors From Italian Ministry Of Health And Related Agencies Suggesting Broad Applicability Of Ampligen To Multiple Sclerosis 9/23/2015
More Than 50 Presentations Of New Data From Sanofi Genzyme (SNY)’s Multiple Sclerosis Franchise To Be Featured At ECTRIMS 9/23/2015
ViiV Healthcare Release: New Phase IIIb/IV Data Show Switching To Once-Daily Triumeq Maintains HIV Viral Suppression 9/23/2015
MerLion Pharmaceuticals GmbH’s Finafloxacin Shown To Be More Efficacious Than Ciprofloxacin In The Treatment Of Complicated Urinary Tract Infections 9/21/2015
ERS 2015: Landmark Year For Boehringer Ingelheim’s Respiratory Portfolio - New Data For COPD, IPF And Asthma Treatments 9/21/2015
AmpliPhi Biosciences Corporation (APHB) Announces Data Demonstrating Efficacy Of A Novel Bacteriophage Cocktail Is Comparable To Vancomycin In S. Aureus Lung Infection Model 9/21/2015
New Treatment Options For Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According To Study By The Medicines Company (MDCO) 9/21/2015
Eli Lilly (LLY) Diabetes Drug Slashes Deaths in Patients With Heart Risk 9/18/2015
Merck & Co. (MRK)'s Once-Weekly Diabetes Drug Works Same as Januvia; Drugmaker Plans to File Drug by End of 2015 9/17/2015
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says 9/17/2015
Amicus (FOLD) Plans To Submit New Drug Application (NDA) For Migalastat For Fabry Disease Following Positive Pre-NDA Meeting With FDA 9/15/2015
GlaxoSmithKline (GSK), Theravance (THRX)'s Breo Fails to Extend Lives in Ambitious Study 9/10/2015
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Enroll First Patient In Phase 4 AUGUSTUS Trial To Evaluate Safety Of Eliquis (Apixaban) In Nonvalvular Atrial Fibrillation Patients With A Recent Acute Coronary Syndrome Or Undergoing Percutaneous Coronary Intervention 9/9/2015
GlaxoSmithKline (GSK) And Theravance (THRX) Announce Results From The SUMMIT COPD CV Survival Study 9/9/2015
DelMar Pharmaceuticals Presents Clinical Protocol For Advancement Of VAL-083 Into Phase IV Studies As A Treatment For Non-Small Cell Lung Cancer 9/8/2015
Collegium (COLL) To Present Highlights From Xtampza ER (Oxycodone Extended-Release Capsules) Clinical Development Program At Painweek 9/4/2015
Regeneron (REGN) And Sanofi (SNY) Announce New Positive Praluent (alirocumab) Phase 3 Data Presented At ESC Congress 2015 9/1/2015
Merck & Co. (MRK) Release: New Analyses From The IMPROVE-IT Study With VYTORIN (Ezetimibe And Simvastatin) 9/1/2015
Boehringer Ingelheim Release: New Analysis Shows Idarucizumab Enables Rapid Initiation Of Emergency Surgery In Dabigatran-Treated Patients 9/1/2015
Eli Lilly (LLY)'s Diabetes Drug Jardiance May Put the Brakes on Heart Disease 8/28/2015
Merck & Co. (MRK) Release: New Analyses From The IMPROVE-IT Outcomes Study Of VYTORIN (Ezetimibe And Simvastatin) And The TECOS Cardiovascular Safety Trial Of JANUVIA (Sitagliptin) Will Be Presented At The European Society of Cardiology Congress 8/20/2015
Intarcia Diabetes Implant Beats Merck & Co. (MRK)'s $6 Billion Drug in Head-to-Head Study 8/20/2015
Novartis AG (NVS) Reports Third Case of PML in Relapsing MS Patient Treated with Gilenya 8/19/2015
Veloxis Pharmaceuticals A/S (VELO) Envarsus XR Granted Orphan Drug Status By FDA For Kidney Transplant Rejection Prophylaxis 8/17/2015
GlaxoSmithKline (GSK) Hopes Huge Trial Will Revive Flagging Lung Drug Biz 8/14/2015
Roche (RHHBY)'s Avastin Not Linked to Higher Risk of Blindness 8/14/2015
Results From First Human Clinical Study Demonstrate ChromaDex, Inc.'s NIAGEN Nicotinamide Riboside Effectively Increases The Co-Enzyme NAD+ And Is Safe 8/12/2015
Oasmia's Paclical Does Well in Head to Head Study with Celgene (CELG)'s Abraxane 8/4/2015
Pfizer (PFE) Pulls Plug on OTC Lipitor After Trial Failure 7/30/2015
Takeda (TKPYY) Announces Completion Of The Pioglitazone Post-Marketing Commitment And Submission Of Results To The European Medicines Agency, The European Medicines Agency And The PMDA 7/30/2015
AVANIR Pharmaceuticals (AVNR) Announces New Findings From Dementia/Alzheimer's Disease Cohort Of PRISM II Study At Alzheimer's Association International Conference 7/23/2015
Portola Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin Complex Concentrate Did Not 6/25/2015
Collegium (COLL) Announces Publication of "Comparing the Effect Of Tampering On The Oral Pharmacokinetic Profiles Of Two Extended-Release Oxycodone Formulations With Abuse-Deterrent Properties," In Pain Medicine 6/25/2015
Egalet's Abuse-Deterrent, Extended-Release Morphine Demonstrates Bioequivalence At 60 Mg Dose 6/25/2015
Protein Sciences Corporation Release: New Clinical Study of Flublok Influenza Vaccine Shows That Groundbreaking Flublok Is More Effective Than The Traditional Flu Shot 6/25/2015
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus XR Demonstrates Differentiated Pharmacokinetic Profile Compared To Twice-Daily Prograf Or Once-Daily Astagraf XL In Stable Kidney Transplant Patients 6/24/2015
MediciNova, Inc. Announces New Article Published On MN-166 (Ibudilast) In Addiction Biology 6/16/2015
Kyowa Hakko USA, Inc. Release: Combination Setria Glutathione And L-Citrulline Supplementation Proven To Increase Post-Exercise Benefits 6/15/2015
Vernalis PLC (VNLPY.PK) Announces CCP-07 Starts 12 Month Stability Testing 6/11/2015
Zealand Pharma  (ZEAL.CO) Informs That Data Presented From The ELIXA Study Establish Lyxumia As The First GLP-1 Receptor Agonist With Cardiovascular Safety Proven In A Long-Term Outcome Trial 6/9/2015
Zealand Pharma  (ZEAL.CO) Informs Of Updates Given By Sanofi (SAN.PA) On Lyxumia And Lixilan On An IR Thematic Conference Call On Diabetes 6/9/2015
Zealand Pharma  (ZEAL.CO) Announces That Sanofi (SAN.PA) Has Informed Of Results From Getgoal Duo-2, Showing Advantages Of Lyxumia Versus Rapid-Acting Insulin As Add-On To Lantus For The Treatment Of Type 2 Diabete 6/8/2015
New Data Show Superiority of Eli Lilly (LLY)'s Once-Weekly Trulicity (dulaglutide) to Lantus (insulin glargine) in Patients with Type 2 Diabetes 6/8/2015
Sanofi (SAN.PA) Announces Study Program Evaluating Toujeo In A Real-Life Setting 6/4/2015
Matinas BioPharma's MAT9001 Meets Primary And Secondary Endpoints In First Human Trial Versus Vascepa 6/1/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Study Commences For Patients With Two Relapsed/Refractory Blood Cancers 5/28/2015
FDA Grants Fast Track Designation For IntelliPharmaCeutics Rexista Oxycodone XR Incorporating PODRAS Technology 5/26/2015
Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial 5/18/2015
AbbVie (ABBV) Receives Orphan Drug Designation For HUMIRA (Adalimumab) From The FDA For The Investigational Treatment Of Moderate-To-Severe Hidradenitis Suppurativa (HS) 5/15/2015
Orexigen (OREX) Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals 5/13/2015
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015
Orexigen (OREX) Aborts Required Study For Diet Drug Contrave 5/13/2015
Heart-Stopping Morning Leads to Vertex (VRTX) Rise As FDA News Sees Positives 5/11/2015
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation By The Hemispherx Biopharma (HEB) For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 5/11/2015
Bristol-Myers Squibb (BMY) Release: Long-Term, 7-Year Study Of Nulojix (Belatacept) Regimen Demonstrates Statistically Significant Relative Risk Reduction Of Death Or Graft Loss Over Cyclosporine Regimen In Kidney Transplant 5/6/2015